Position in BBIO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$75,299
New position
Shares Held
1,014
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Derivatives in BBIO
reported options exposure · as of Mar 31, 2026CallValue
$460,412
CallShares
6,200
PutValue
$519,820
PutShares
7,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Alphadyne Asset Management LP holds $5,118,929 across 5 Biotechnology names. BBIO ranks #5 (1.5% of the industry book) .
All Filings in BBIO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $519,820 | 7,000 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $460,412 | 6,200 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $75,299 | 1,014 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||